TARS vs W · rev $183.0M vs rev $11.85B
Tarsus Pharmaceuticals Inc (TARS) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
TARS currently screens at market cap $2.66B. W currently screens at market cap $10.77B.
Not investment advice. Open the TARS and W stock pages for the full models.
Not investment advice.